Precision Neuroscience’s Chief Science Officer & Co-Founder, Benjamin Rapoport, recently presented alongside Dr. Sergey Stavisky of the University of California, Davis, as part of the BCI Society’s “Industry and Academia” series. Dr. Stavisky’s presentation showcased some of the most exciting brain-computer interface work coming out of academia, by his team at UC Davis. Using existing, wired BCI implants (the Utah array), the team achieved remarkable accuracy in decoding speech from an ALS patient with severe speech deficits. The patient was able to communicate using a comprehensive vocabulary (125,000 words) only two days after his implant, and was able to use the neuroprosthesis to have natural, self-paced conversations with family, friends, healthcare professionals and colleagues. We were especially moved by footage of the patient, a man in his forties, speaking to his young daughter through the computer system. An excerpt from their conversation: How was… your day Sweet daughter of mine I have been waiting for this for a long time Dr. Rapoport’s presentation starts around the 33 minute mark. He gives a technical deep dive into the work that Precision is doing to build a next-generation version of this technology, and shares some of the early results that Precision has been seeing in the clinic. Watch the #BCIThursdays video below.
Precision Neuroscience
Medical Equipment Manufacturing
Manhattan, NY 16,626 followers
About us
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.
- Website
-
http://precisionneuro.io
External link for Precision Neuroscience
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Manhattan, NY
- Type
- Privately Held
- Specialties
- brain-computer interfaces, medical device, neuroscience, neurology, and BCI
Locations
-
Primary
Manhattan, NY 10010, US
-
Mountain View, CA, US
-
Bloomington, MN, US
Employees at Precision Neuroscience
-
Ludwig Pierre Schulze
Managing Partner @ Alumni Ventures
-
Gabe Greenbaum
General Partner @ B Capital Group | MBA, JD | Early and Growth Stage Venture Capital
-
Joe Sharron
The Team at Precision -Ex Neuralink -C3/C4 SCI -Inspiring people of all abilities- Ex HubSpot
-
Craig Mermel
President and Chief Product Officer @ Precision Neuroscience
Updates
-
The The Wall Street Journal has a helpful visual primer on Neuralink and the other leading contenders in the brain–computer interface (BCI) space, all of whom are working to restore function for severely paralyzed people. Note that Precision Neuroscience's implant is the only one in this group that is both high-bandwidth–with 1,024 electrodes streaming realtime data from the brain–and minimally invasive. It sits on top of the brain’s cortex, causing zero damage to its delicate tissue. Synchron Paradromics Inc. Blackrock Neurotech #BrainComputerInterface
-
Attending the 11th Annual Meeting of the Subcortical Surgery Group this week in Boulder, Colorado? Make sure to catch the NeuraSeed BCI Expo 2024 "A Virtual World's Fair for BCI", tomorrow, Friday, August 2nd from 12pm to 5pm MST. The NeuraSeed BCI Expo 2024 will feature presentations, panels, and exhibits from BCI leaders who are advancing research, product development, and clinical translation for emerging applications of brain-computer interface (BCI) technology. Speakers from Precision Neuroscience will include Dr. Benjamin Rapoport, Precisions's Co-Founder & Chief Science Officer, Craig Mermel, President & Chief Product Officer, and Jayme Strauss RN,MSN,MBA,SCRN, Chief Clinical & Commercial Officer. All three will bring their experience, passion and expertise in the world of BCIs, outline Precision's minimally invasive approach, and discuss what all of this means for millions of people suffering from devastating neurological conditions. Make sure to stop by the Precision Neuroscience Virtual Booth too! Sign up for free to attend the NeuraSeed BCI Expo virtually: https://lnkd.in/eYERdpEU Learn more about the NeuraSeed BCI Expo 2024 here: https://lnkd.in/ejYM5mCH
-
-
Fascinating article from the folks at NEUROTECH FUTURES, who recently sat down with Dr. Benjamin Rapoport to learn about his work as co-founder of Precision Neuroscience and his perspective on several emergent topics in BCI commercialization. Ben discusses his time at Elon Musk’s Neuralink, the reasons he left, and how those reasons became the foundation for a new brain-computer interface company, Precision Neuroscience. The article also addresses the clinical practice guidelines for brain-computer interfaces, explantation (a topic nobody in BCI talks about), and the referral pathways that will inform the patient’s journey to getting a BCI in the near future. Read the full article below for more... #Neurotech #BrainComputerInterface #BrainTumorSurgery #BrainSurgery #Neurosurgery #Neurosurgeon
Building BCI For the Real World: A Chat With Dr. Benjamin Rapoport of Precision Neuroscience
neurotechnology.substack.com
-
I have the honor of announcing Dr. Craig Mermel, President and Chief Product Officer at Precision Neuroscience, as our next speaker in our conference series. Dr. Mermel earned his MD/PhD from Harvard University and is a seasoned expert in cancer genomics and pathology. Simbionics, a digital health company he co-founded with Dr. Benjamin Rapoport was later acquired by Apple where he was instrumental in the early development of biosensors. He then spearheaded AI computer vision application to medical imaging data at Google Health. When I met with Dr. Mermel, I was inspired by the multidisciplinary nature of his career, making his impact in billion dollar companies of Apple and Google along the way and now in BCI at Precision Neuroscience. I would like to extend a warm welcome to Dr. Craig Mermel and I look forward to working collaboratively with him in the BCI and oncology spaces. - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair
-
-
It is an honor to announce our newest speaker for the NeuraSeed BCI Expo 2024, Jayme Strauss RN,MSN,MBA,SCRN, and congratulate her on her newest role as Chief Commercial and Clinical Officer at Precision Neuroscience. Jayme’s background is as a seasoned ICU nurse where she provided direct care to a variety of patients including those on trauma, neurology, and burn units. She then gained over a decade of experience leading programs in a variety of medical specialties with a particular commitment to stroke management. She also served as Executive Director of Neurosciences at Piedmont Healthcare, a network of over 11 hospitals. As former Chief Clinical Officer at Viz.ai, she spearheaded AI solutions that revolutionize the diagnosis and treatment of neurological conditions across a variety of markets. When I met Jayme, learning about her personal and professional journey has been a great inspiration. Her insights range from the true day-to-day patient experience to global innovations in healthcare. She is incredibly passionate about making a positive impact on the lives of patients and their families. NeuraSeed BCI is incredibly fortunate to have Jayme share her journey and insights. - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair
-
-
We are excited to announce two more additions to the Precision Neuroscience leadership team. Jayme Strauss RN,MSN,MBA,SCRN has joined the company as Chief Clinical and Commercial Officer, and Mike Kaswan has joined as Chief Financial Officer. Jayme and Mike will apply their decades of experience in healthcare innovation to accelerate Precision's mission to deliver on the promise of neurotechnology to transform brain health! Read the full news release below.
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
globenewswire.com
-
Precision Neuroscience / Precision BioMEMS will be part of the "BCI: State of the Art, Art of the Future" panel discussion this week at the IEEE Engineering Medicine and Biology Society 2024 conference, the world’s largest international biomedical engineering conference, currently underway in Orlando. Stop by the panel session on July 18th, for what promises to be a lively and informative discussion on brain-computer interfaces and their implications for the future of healthcare. #EMBC2024
-
-
Precision BioMEMS / Precision Neuroscience are proud to be an official sponsor of the 46th Annual International Conference of the IEEE Engineering Medicine and Biology Society, taking place in Orlando, July 15 - 19, 2024. Precision is honored to support IEEE’s vision for the 2024 conference: “Technology and its promise for equity and access for well-health,” which will address the positive impacts that engineering can have on the whole of society. The conference will cover a broad array of scientific tracks, from cutting-edge research in biomedical engineering to healthcare technology, in particular for women and children’s health. Stop by the Precision booth at IEEE EMBC 2024 to learn about Precision BioMEMS, our wholly owned and operated MEMS facility that produces our biocompatible microelectrode arrays and offers foundry services to pioneering third-party companies.
-
-
Join Precision Neuroscience’s Head of Microfabrication, Mark Hettick, today at the FLEX / SEMICON WEST 2024 Precision BioMEMS FLEXTalks presentation: “BioMEMS and FLEX Electronics: Medical FLEX Applications and a Foundry to Serve Them”. The topics among Mark’s talk will include the explosion of neurotech and the growing field of implantable MEMS, applications of flexible electronics, and new BioMEMS structures that are becoming increasingly relevant. Tuesday, July 9th, 2.20pm - 2.35pm at the Smart Stage FLEX Theater in the South Expo Hall (by the FLEX Exhibits) #SEMICONWest #SEMI_FLEX #BioMEMS #MicroFluidics #MedicalMEMS
-